Media Lab S.p.A. (MLLAB.PA)
ValueMarkers Composite Index
36% below intrinsic value ($6)
Media Lab S.p.A. (MLLAB.PA) — VMCI valuation read
Composite valuation read on MLLAB.PA: VMCI 61/100 against a Healthcare sector median of 50. The 11-point above-median print is the headline number for Media Lab S.p.A., and at the mid-cap tier it reflects how the five pillars combine into a single decision-grade score.
Trailing 30-day insider activity for MLLAB.PA: nothing material on SEC EDGAR. With the Form 4 channel quiet, the price-vs-DCF gap and the trailing margin trend carry more weight in the active read.
**Investor frame.** Value, quality, risk in three lines on MLLAB.PA: MLLAB.PA trades at 21.0x earnings, 17% above the Healthcare median of 18.0x; ROIC of 17.0% sits 7.0pp above the Healthcare median (10.0%); net debt to EBITDA of 2.0x is the rate-sensitivity line to watch. EV/EBITDA at 14.0x versus 12.0x for Healthcare closes the value frame.
MLLAB.PA fell 1.8% over the trailing 7 days, with a +6.3% read on a 30-day basis.
Related Stocks in Healthcare
Top peers ranked by VM Score. Compare valuation, quality, and risk metrics across the sector.